Cancer is a global health concern, claiming the lives of about 10 million people in 2020 alone. However, when we turn our attention to Arab countries in the Middle East, a fascinating observation emerges. Despite the growing incidence of cancer in the region, the figures remain significantly lower compared to Western countries. In this article, we delve into various factors that might contribute to this discrepancy, ranging from lifestyle choices to genetic predispositions.
In 2020, cancer was responsible for a staggering number of deaths worldwide, with breast, lung, colon, and rectum cancers leading the charts. Alarmingly, long-term projections for the Middle East indicate a 1.8-fold increase in cancer incidence by 2030. Yet, when we examine the reported figures, Arab countries exhibit considerably lower rates than Western counterparts.
Australia and New Zealand top the list of countries with the highest cancer rates, reporting 452.4 and 422.9 cases per 100,000 people, respectively. In contrast, Middle East countries, with Egypt and Lebanon leading the pack, report significantly lower figures, with Saudi Arabia and Sudan at the bottom of the list.
One intriguing aspect is the practice of fasting, particularly during Ramadan. This religious rite involves abstaining from food and drink from dawn to dusk for a month. Research suggests that intermittent fasting might play a role in cancer prevention and treatment. It is believed that healthy cells adapt better to nutrient scarcity, while cancer cells struggle to grow in such conditions. Some studies propose that fasting may enhance cancer cell sensitivity to chemotherapy, protecting normal cells and promoting stem cell production.
The rich use of spices in Arab cuisine is another factor that may contribute to lower cancer rates.
The link between alcohol, cigarette smoking, and various cancers is well-documented. Interestingly, the Middle East shows significantly lower rates of female smoking compared to Western countries, and alcohol is prohibited in many Islamic nations.
Despite the changing incidence rates of breast cancer in the Middle East, genetic factors such as mutations in the BRCA1 and BRCA2 genes appear less prevalent among Arab populations compared to other ethnic groups.
The Middle East experiences an accelerated incidence of some cancers, often attributed to adverse lifestyle choices and westernization. However, the overall cancer rates remain lower than those reported in Western countries. Clinical trials are crucial to understand the impact of caloric restriction, fasting, and dietary patterns in the Middle East on cancer incidence. Additionally, exploring hereditary cancer genes across the Arab world is essential for a comprehensive understanding of the observed patterns.